Crossref
journal-article
Rockefeller University Press
The Journal of Experimental Medicine (291)
References
15
Referenced
206
10.1146/annurev.cellbio.15.1.269
/ Annu. Rev. Cell Dev. Biol / Biochemical pathways of caspase activation during apoptosis by Budihardjo (1999)10.1016/S0092-8674(00)00003-9
/ Cell / Apoptotic pathwayspaper wraps stone blunts scissors by Green (2000)10.1126/science.288.5475.2354
/ Science / Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations by Siegel (2000)10.1126/science.288.5475.2351
/ Science / A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling by Chan (2000)10.1093/emboj/17.6.1675
/ EMBO (Eur. Mol. Biol. Organ.) J / Two CD95 (APO-1/Fas) signaling pathways by Scaffidi (1998)10.1074/jbc.274.32.22532
/ J. Biol. Chem / Differential modulation of apoptosis sensitivity in CD95 type I and type II cells by Scaffidi (1999)10.1016/S0092-8674(00)81589-5
/ Cell / Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors by Luo (1998)10.1016/S0092-8674(00)81590-1
/ Cell / Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis by Li (1998)10.1038/nm0196-80
/ Nat. Med / Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice by Lacronique (1996)10.1084/jem.183.3.1031
/ J. Exp. Med / A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection by Rodriguez (1996)10.1038/23730
/ Nature / Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis by Yin (1999)10.1073/pnas.96.26.14871
/ Proc. Natl. Acad. Sci. USA / Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L) by Huang (1999)10.1038/sj.cdd.4400569
/ Cell Death Differ / Differences between CD95 type I and II cells detected with the CD95 ligand by Schmitz (1999)10.1038/sj.cdd.4400683
/ Cell Death Differ. / Bcl-2 does not inhibit cell death induced by the physiological Fas ligandimplications for the existence of type I and type II cells by Huang (2000)10.1084/jem.192.5.647
/ J. Exp. Med. / Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinaseregulators of distinct cell death and survival pathways in granulocytes by Villunger (2000)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 12:48 p.m.) |
Deposited | 2 years, 1 month ago (July 25, 2023, 6:43 a.m.) |
Indexed | 1 week ago (Aug. 20, 2025, 8:36 a.m.) |
Issued | 24 years, 10 months ago (Oct. 16, 2000) |
Published | 24 years, 10 months ago (Oct. 16, 2000) |
Published Online | 24 years, 10 months ago (Oct. 16, 2000) |
Published Print | 24 years, 10 months ago (Oct. 16, 2000) |
@article{Roy_2000, title={Cross-Talk in Cell Death Signaling}, volume={192}, ISSN={1540-9538}, url={http://dx.doi.org/10.1084/jem.192.8.f21}, DOI={10.1084/jem.192.8.f21}, number={8}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Roy, Sophie and Nicholson, Donald W.}, year={2000}, month=oct, pages={F21–F26} }